Boston Scientific beats Q3 expectations, raises 2025 guidance amid strong performance in key franchises like WATCHMAN and FARAPULSE/pulsed-field ablation.
Elderly passenger left behind on remote island during Coral Adventurer cruise dies, sparking investigation and refunds.
Boston Scientific beats Q3 expectations, raises 2025 guidance amid strong performance in key franchises like WATCHMAN and FARAPULSE/pulsed-field ablation.
Elderly passenger left behind on remote island during Coral Adventurer cruise dies, sparking investigation and refunds.